Fulcrum Therapeutics Inc
FULC
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company whose drug development pipeline relies on animal testing. The company’s lead product candidates, including its investigational treatments for rare diseases, have progressed through preclinical studies involving animal models. This use of animals in research is a standard, integral component of its business model for regulatory approval.
A 2025 shareholder class action lawsuit, *Celano v. Fulcrum Therapeutics*, alleged the company made misleading statements regarding the efficacy and viability of a lead product candidate. While the suit centered on securities fraud allegations, such litigation often involves scrutiny of preclinical data generated from animal studies. Fulcrum’s operations remain dependent on animal testing to advance its therapeutic programs.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.